Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL DE PHARMACIENS D'OFFICINE BRIOL : revenue, balance sheet and financial ratios

SPFPL DE PHARMACIENS D'OFFICINE BRIOL is a French company founded 10 years ago, specialized in the sector Activités des sociétés holding. Based in OLORON-SAINTE-MARIE (64400), this company of category PME shows in 2025 a net income negative of -15 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL DE PHARMACIENS D'OFFICINE BRIOL (SIREN 811880301)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income -14 607 € -4 395 € -5 704 € 76 906 € 75 700 € 73 517 € 72 132 € 34 404 € -9 995 €
EBITDA -2 546 € -6 136 € -1 527 € -1 452 € -2 026 € -3 290 € -3 024 € -3 750 € -3 277 €
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, SPFPL DE PHARMACIENS D'OFFICINE BRIOL records a net loss of 15 k€. This deficit will reduce equity on the balance sheet.

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-2 546 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-2 546 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-14 607 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 20%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 84%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

19.546%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

83.65%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-19.958

Solvency indicators evolution
SPFPL DE PHARMACIENS D'OFFICINE BRIOL

Sector positioning

Debt ratio
19.55 2025
2023
2024
2025
Q1: 0.04
Med: 8.09
Q3: 54.01
Average +11 pts over 3 years

In 2025, the debt ratio of SPFPL DE PHARMACIENS D'OF... (19.55) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
83.65% 2025
2023
2024
2025
Q1: 21.27%
Med: 67.32%
Q3: 92.99%
Good -9 pts over 3 years

In 2025, the financial autonomy of SPFPL DE PHARMACIENS D'OF... (83.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
-19.96 years 2025
2023
2024
2025
Q1: 0.0 years
Med: 0.19 years
Q3: 2.98 years
Excellent

In 2025, the repayment capacity of SPFPL DE PHARMACIENS D'OF... (-19.96) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-473.723

Liquidity indicators evolution
SPFPL DE PHARMACIENS D'OFFICINE BRIOL

Sector positioning

Interest coverage
-473.72x 2025
2023
2024
2025
Q1: -62.1x
Med: 0.0x
Q3: 0.0x
Average

In 2025, the interest coverage of SPFPL DE PHARMACIENS D'OF... (-473.7x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SPFPL DE PHARMACIENS D'OFFICINE BRIOL

Positioning of SPFPL DE PHARMACIENS D'OFFICINE BRIOL in its sector

Comparison with sector Activités des sociétés holding

Similar companies (Activités des sociétés holding)

Compare SPFPL DE PHARMACIENS D'OFFICINE BRIOL with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des sociétés holding

Frequently asked questions about SPFPL DE PHARMACIENS D'OFFICINE BRIOL

What is the revenue of SPFPL DE PHARMACIENS D'OFFICINE BRIOL ?

The revenue of SPFPL DE PHARMACIENS D'OFFICINE BRIOL is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL DE PHARMACIENS D'OFFICINE BRIOL profitable?

SPFPL DE PHARMACIENS D'OFFICINE BRIOL recorded a net loss in 2025.

Where is the headquarters of SPFPL DE PHARMACIENS D'OFFICINE BRIOL ?

The headquarters of SPFPL DE PHARMACIENS D'OFFICINE BRIOL is located in OLORON-SAINTE-MARIE (64400), in the department Pyrenees-Atlantiques.

Where to find the tax return of SPFPL DE PHARMACIENS D'OFFICINE BRIOL ?

The tax return of SPFPL DE PHARMACIENS D'OFFICINE BRIOL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL DE PHARMACIENS D'OFFICINE BRIOL operate?

SPFPL DE PHARMACIENS D'OFFICINE BRIOL operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.